Invention Grant
- Patent Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
-
Application No.: US13952278Application Date: 2013-07-26
-
Publication No.: US08952157B2Publication Date: 2015-02-10
- Inventor: Hong Ding , George A. Doherty , Steven W. Elmore , Laura Hexamer , Aaron R. Kunzer , Cheol-Min Park , Xiahong Song , Andrew J. Souers , Gerard M. Sullivan , Zhi-Fu Tao , Le Wang , Michael D. Wendt , Peter Edward Czabotar , Guillaume Laurent Lessene , Peter Malcolm Colman
- Applicant: AbbVie Inc. , The Walter and Eliza Hall Institue of Medical Research
- Applicant Address: US IL North Chicago AU Victoria
- Assignee: AbbVie Inc.,The Walter and Eliza Hall Institute of Medical Research
- Current Assignee: AbbVie Inc.,The Walter and Eliza Hall Institute of Medical Research
- Current Assignee Address: US IL North Chicago AU Victoria
- Agency: Jones Day
- Main IPC: C07D241/12
- IPC: C07D241/12 ; C07D401/10 ; C07D401/12 ; C07D209/08 ; C07D211/58 ; C07D213/74 ; C07D213/84 ; C07D231/56 ; C07D235/06 ; C07D277/24 ; C07D295/30 ; C07D309/04 ; C07D401/14 ; C07D403/12 ; C07D405/12 ; C07D405/14 ; C07D413/12 ; C07D417/12 ; C07D471/04 ; C07D309/08
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Public/Granted literature
- US20140066621A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Public/Granted day:2014-03-06
Information query
